Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Puma Biotechnology
PBYI
|
+$276M |
| 2 |
Home Depot
HD
|
+$240M |
| 3 |
TE Connectivity
TEL
|
+$232M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$191M |
| 5 |
SHPG
Shire pic
SHPG
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$279M |
| 2 |
Meta Platforms (Facebook)
META
|
+$271M |
| 3 |
NVIDIA
NVDA
|
+$233M |
| 4 |
Cadence Design Systems
CDNS
|
+$222M |
| 5 |
CSX Corp
CSX
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.46% |
| 2 | Healthcare | 15.52% |
| 3 | Financials | 13.32% |
| 4 | Industrials | 12.73% |
| 5 | Consumer Discretionary | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
First Solar
FSLR
$21.8B
| $6.16M | ﹤0.01% |
91,200
+58,100
| +176% | +$3.41M |
|
|
LPT
952
DELISTED
Liberty Property Trust
LPT
| $6.12M | ﹤0.01% |
142,342
-3,300
| -2% | -$143K |
|
953
Brookfield
BN
$102B
| $6.1M | ﹤0.01% |
392,657
-24,989
| -6% | -$377K |
|
954
Booz Allen Hamilton
BAH
$8.7B
| $6.05M | ﹤0.01% |
158,600
+114,200
| +257% | +$4.32M |
|
955
Chord Energy
CHRD
$7.79B
| $6.02M | ﹤0.01% |
716,171
+352,325
| +97% | +$3.25M |
|
|
GAP
956
The Gap Inc
GAP
$6.84B
| $6M | ﹤0.01% |
176,111
+81,115
| +85% | +$2.42M |
|
957
Devon Energy
DVN
$51.9B
| $5.8M | ﹤0.01% |
140,117
+7,081
| +5% | +$268K |
|
|
CNR
958
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $5.79M | ﹤0.01% |
+300,000
| New | +$5.05M |
|
959
Campbell Soup
CPB
$6.51B
| $5.75M | ﹤0.01% |
119,546
-168,163
| -58% | -$7.99M |
|
960
CarMax
KMX
$8.27B
| $5.73M | ﹤0.01% |
89,393
+17,193
| +24% | +$1.23M |
|
961
Huntington Bancshares
HBAN
$35.1B
| $5.7M | ﹤0.01% |
391,126
-738,600
| -65% | -$10.4M |
|
|
S
962
DELISTED
Sprint Corporation
S
| $5.7M | ﹤0.01% |
967,010
-1,764,476
| -65% | -$11.2M |
|
963
Post Holdings
POST
$4.12B
| $5.64M | ﹤0.01% |
108,702
+103,201
| +1,876% | +$5.49M |
|
964
Charles River Laboratories
CRL
$10.9B
| $5.59M | ﹤0.01% |
51,100
+46,900
| +1,117% | +$5.1M |
|
965
Lear
LEA
$7.19B
| $5.59M | ﹤0.01% |
31,649
-4,848
| -13% | -$851K |
|
966
United Therapeutics
UTHR
$26.3B
| $5.57M | ﹤0.01% |
37,626
-8,920
| -19% | -$1.13M |
|
967
Masco
MAS
$16B
| $5.56M | ﹤0.01% |
126,496
+1,600
| +1% | +$65K |
|
968
Nucor
NUE
$56.4B
| $5.56M | ﹤0.01% |
87,395
-11,808
| -12% | -$691K |
|
969
Cardinal Health
CAH
$53.4B
| $5.54M | ﹤0.01% |
90,336
-18,594
| -17% | -$1.15M |
|
|
CRC
970
DELISTED
California Resources Corporation
CRC
| $5.53M | ﹤0.01% |
284,403
-532,845
| -65% | -$7.48M |
|
971
Pentair
PNR
$10.2B
| $5.53M | ﹤0.01% |
116,523
-15,486
| -12% | -$724K |
|
972
Huntsman Corp
HUN
$2.24B
| $5.47M | ﹤0.01% |
164,400
+76,100
| +86% | +$2.33M |
|
973
AptarGroup
ATR
$8.45B
| $5.44M | ﹤0.01% |
63,000
+19,300
| +44% | +$1.68M |
|
|
NBD
974
DELISTED
Nuveen Build Am Bond Opp Fd
NBD
| $5.43M | ﹤0.01% |
235,541
+907
| +0.4% | +$20.5K |
|
975
NOV
NOV
$7.45B
| $5.39M | ﹤0.01% |
149,714
-2,134
| -1% | -$72.2K |
|
Similar funds
Janus Henderson Group's Q4 2017 Portfolio in Review
As of Q4 2017, Janus Henderson Group held 1,379 positions worth $165B, up 5.4% from $156B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q4 2017 filing shows 95 new, 535 increased, 621 reduced and 76 closed positions. Its largest new stake was Invitation Homes: 5,558,350 shares worth $131M. The largest sale was Lowe's Companies, an estimated $279M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2017 buy was Invitation Homes: 5,558,350 shares worth $131M.
- Janus Henderson Group added most to Puma Biotechnology in Q4 2017, an estimated $276M increase.
- Janus Henderson Group's biggest Q4 2017 reduction was Lowe's Companies, cutting an estimated $279M.
- Janus Henderson Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $124M.
- Janus Henderson Group's ten largest holdings make up 14% of its $165B portfolio in Q4 2017.
- Janus Henderson Group opened 95 new positions and closed 76 in Q4 2017.
- Janus Henderson Group's portfolio value rose 5.4% quarter-over-quarter to $165B.
Based on Janus Henderson Group's 13F filing for Q4 2017, filed 9 Feb 2018.